 E88 |
 |
Other and unspecified metabolic disorders  |
| |
| UseAdditionalCode |
codes for associated conditions
|
| Excludes1 |
histiocytosis X (chronic) (C96.6)
|
|
| |
| E88.0 |
|
Disorders of plasma-protein metabolism, not elsewhere classified |
| |
| Excludes1 |
monoclonal gammopathy (of undetermined significance) (D47.2)
polyclonal hypergammaglobulinemia (D89.0)
Waldenström macroglobulinemia (C88.00)
|
| Excludes2 |
disorder of lipoprotein metabolism (E78.-)
|
|
| |
 E88.01 |
|
Alpha-1-antitrypsin deficiency |
| |
|
| | |
| E88.02 |
|
Plasminogen deficiency |
| |
| Dysplasminogenemia | | Hypoplasminogenemia | | Type 1 plasminogen deficiency | | Type 2 plasminogen deficiency |
| CodeAlso |
, if applicable, ligneous conjunctivitis (H10.51)
|
| UseAdditionalCode |
code for associated findings, such as:
hydrocephalus (G91.4)
otitis media (H67.-)
respiratory disorder related to plasminogen deficiency (J99)
|
|
| | |
| E88.09 |
|
Other disorders of plasma-protein metabolism, not elsewhere classified |
| |
|
| |
| |
| E88.1 |
|
Lipodystrophy, not elsewhere classified |
| |
| Lipodystrophy NOS |
| Excludes1 |
Whipple's disease (K90.81)
|
|
|
| |
| E88.2 |
|
Lipomatosis, not elsewhere classified |
| |
| Lipomatosis NOS | | Lipomatosis (Check) dolorosa [Dercum] |
|
|
| |
| E88.3 |
|
Tumor lysis syndrome |
| |
| Tumor lysis syndrome (spontaneous) | | Tumor lysis syndrome following antineoplastic drug chemotherapy |
| UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T45.1X5)
|
|
|
| |
| E88.4 |
|
Mitochondrial metabolism disorders |
| |
| Excludes1 |
disorders of pyruvate metabolism (E74.4)
Kearns-Sayre syndrome (H49.81)
Leber's disease (H47.22)
Leigh's encephalopathy (G31.82)
Mitochondrial myopathy, NEC (G71.3)
Reye's syndrome (G93.7)
|
|
| |
| E88.40 |
|
Mitochondrial metabolism disorder, unspecified |
| | |
| E88.41 |
|
MELAS syndrome |
| |
| Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes |
|
| | |
| E88.42 |
|
MERRF syndrome |
| |
| Myoclonic epilepsy associated with ragged-red fibers |
| CodeAlso |
progressive myoclonic epilepsy (G40.3-)
|
|
| | |
| E88.43 |
|
Disorders of mitochondrial tRNA synthetases |
| | |
| E88.49 |
|
Other mitochondrial metabolism disorders |
| |
| |
| E88.8 |
|
Other specified metabolic disorders |
| |
| E88.81 |
|
Metabolic syndrome and other insulin resistance |
| |
| UseAdditionalCode |
codes for associated manifestations, such as:
obesity (E66.-)
|
|
| |
| E88.810 |
|
Metabolic syndrome |
| |
|
| | |
| E88.811 |
|
Insulin resistance syndrome, Type A |
| | |
| E88.818 |
|
Other insulin resistance |
| |
| Insulin resistance syndrome, Type B |
|
| | |
| E88.819 |
|
Insulin resistance, unspecified |
| | | |
| E88.82 |
|
Obesity due to disruption of MC4R pathway |
| |
| UseAdditionalCode |
code, if applicable, to identify associated manifestations, such as polyphagia (R63.2)
|
| UseAdditionalCode |
code to identify body mass index (BMI), if known (Z68.-)
|
|
| | |
| E88.89 |
|
Other specified metabolic disorders |
| |
| Launois-Bensaude adenolipomatosis |
| Excludes1 |
adult pulmonary Langerhans cell histiocytosis (J84.82)
|
|
| |
| |
| E88.9 |
|
Metabolic disorder, unspecified |
|
| |
| E88.A |
|
Wasting disease (syndrome) due to underlying condition |
| |
| Cachexia due to underlying condition |
| CodeFirst |
underlying condition
|
| Excludes1 |
cachexia NOS (R64)
nutritional marasmus (E41)
|
| Excludes2 |
failure to thrive (R62.51, R62.7)
|
|
|